Market Summary
USD6.05+0.01
Market Closed0.17%
MASS Stock Price
MASS RSI Chart
MASS Valuation
MASS Price/Sales (Trailing)
MASS Profitability
MASS Fundamentals
MASS Revenue
MASS Earnings
Price Action
52 Week Range
5.6918.02
(Low)(High)
Last 7 days
-1.1%
Last 30 days
-16.1%
Last 90 days
-10.2%
Trailing 12 Months
-60.1%
MASS Financial Health
MASS Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for MASS
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-06-14 | HRUSOVSKY E KEVIN | acquired | - | - | 4,771 | - |
2023-06-14 | CRANDELL KEITH | acquired | - | - | 4,771 | - |
2023-06-14 | ELOI FENEL M | acquired | - | - | 4,771 | - |
2023-06-14 | George Jeffrey P. | acquired | - | - | 4,771 | - |
2023-06-14 | Hunt Anthony | acquired | - | - | 4,771 | - |
2023-06-14 | Eisenberg Marcia | acquired | - | - | 4,771 | - |
2023-06-14 | Spoto Mark | acquired | - | - | 4,771 | - |
2023-06-07 | Brown Christopher D. | sold | -44,834 | 10.03 | -4,470 | chief product officer |
2023-06-07 | Eisenberg Marcia | acquired | - | - | 681 | - |
2023-06-05 | Knopp Kevin J. | acquired | 49,875 | 1.75 | 28,500 | president and ceo |
Which funds bought or sold MASS recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | reduced | -59.6 | -65,000 | 31,000 | -% |
2023-09-12 | Farther Finance Advisors, LLC | unchanged | - | -28.00 | 110 | -% |
2023-08-22 | COMERICA BANK | new | - | - | - | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -11.19 | -20,598 | 50,051 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -60.4 | -12,596 | 5,949 | -% |
2023-08-16 | Nuveen Asset Management, LLC | added | 62.14 | 146,308 | 646,308 | -% |
2023-08-15 | ALLIANCEBERNSTEIN L.P. | added | 10.14 | -23,088 | 166,972 | -% |
2023-08-15 | Sands Capital Ventures, LLC | reduced | -27.32 | -1,179,680 | 1,627,590 | 0.48% |
2023-08-15 | GOLDMAN SACHS GROUP INC | added | 1,732 | 2,203,960 | 2,365,840 | -% |
2023-08-15 | WELLS FARGO & COMPANY/MN | added | 95.4 | 24,148 | 67,372 | -% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
Schedule 13G FIlings of 908 Devices
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | alger associates inc | 8.8% | 2,805,216 | SC 13G/A | |
| Feb 14, 2023 | eventide asset management, llc | 7.0% | 2,230,665 | SC 13G | |
| Feb 13, 2023 | arch venture fund vii, l.p. | 18.1% | 5,725,045 | SC 13G/A | |
| Feb 01, 2023 | blackrock inc. | 5.6% | 1,763,507 | SC 13G/A | |
| Jul 08, 2022 | blackrock inc. | 7.4% | 2,318,894 | SC 13G | |
| Feb 09, 2022 | ark investment management llc | 9.66% | 2,996,393 | SC 13G/A | |
| Feb 08, 2022 | arch venture fund vii, l.p. | 18.5% | 5,725,045 | SC 13G/A |
Recent SEC filings of 908 Devices
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Aug 08, 2023 | 8-K | Current Report | |
| Aug 08, 2023 | 10-Q | Quarterly Report |
908 Devices News
Returns for MASS
Cumulative Returns on MASS
Risks for MASS
What is the probability of a big loss on MASS?
97.9%
Probability that 908 Devices stock will be more than 20% underwater in next one year
92.4%
Probability that 908 Devices stock will be more than 30% underwater in next one year.
92.4%
Probability that 908 Devices stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does MASS drawdown profile look like?
Y-axis is the maximum loss one would have experienced if 908 Devices was unfortunately bought at previous high price.
Drawdowns
Financials for 908 Devices
Income Statement (Last 12 Months)(In Thousands)
| Income Statement (Last 12 Months) | (In Thousands) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
| Revenue | 2.1% | 49,021 | 48,033 | 46,852 | 51,050 | 47,798 | 44,969 | 42,206 | 32,082 | 25,585 | 28,436 | 26,894 | 28,236 | 30,258 | 16,004 |
| Gross Profit | -3.2% | 25,438 | 26,278 | 26,023 | 29,235 | 26,709 | 24,454 | 23,233 | 16,678 | 13,702 | 15,733 | 14,923 | 16,459 | 17,016 | 8,392 |
| Operating Expenses | 2.7% | 66,886 | 65,156 | 61,405 | 57,807 | 53,403 | 50,234 | 45,302 | 39,105 | 32,146 | 24,594 | 20,738 | 19,031 | 18,288 | 19,448 |
| S&GA Expenses | 1.1% | 46,635 | 46,137 | 43,879 | 41,198 | 38,158 | 36,227 | 32,235 | 27,501 | 21,893 | 15,550 | 12,503 | 11,093 | 10,284 | 10,824 |
| R&D Expenses | 6.5% | 20,225 | 18,993 | 17,500 | 16,609 | 15,245 | 14,007 | 13,067 | 11,604 | 10,253 | 9,044 | 8,235 | 7,937 | 8,004 | 8,624 |
| Interest Expenses | -2.3% | 645 | 660 | 129 | 108 | 106 | 130 | 486 | 690 | 904 | 1,111 | 976 | 976 | 974 | 964 |
| Earnings Before Taxes | -Infinity% | -37,668 | - | - | - | -32,396 | - | - | - | - | - | - | - | - | - |
| Net Income | -3.4% | -37,965 | -36,718 | -33,600 | -27,238 | -26,164 | -25,489 | -22,169 | -28,930 | -25,467 | -15,948 | -12,819 | -3,457 | -1,742 | -11,864 |
| Net Income Margin | 100.0% | - | -0.76* | -0.72* | -0.53* | -0.55* | -0.57* | -0.53* | -0.90* | -0.99* | -0.53* | -0.45* | -0.12* | -0.06* | -0.74* |
| Free Cashflow | 100.0% | - | -33,724 | -22,975 | -26,521 | -23,821 | -21,260 | -29,819 | -18,213 | -6,859 | -6,124 | 2,387 | 2,387 | -13,164 | -13,036 |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
| Assets | -3.5% | 211 | 218 | 243 | 249 | 247 | 251 | 261 | 166 | 166 | 172 | 179 |
| Current Assets | -3.7% | 181 | 188 | 216 | 224 | 239 | 243 | 253 | 157 | 157 | 163 | 171 |
| Cash Equivalents | -17.5% | 133 | 161 | 188 | 194 | 213 | 223 | 224 | 139 | 141 | 149 | 159 |
| Inventory | 5.7% | 14.00 | 13.00 | 13.00 | 12.00 | 11.00 | 10.00 | 8.00 | 8.00 | 8.00 | 7.00 | 5.00 |
| Net PPE | -3.4% | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 |
| Goodwill | -0.4% | 10.00 | 10.00 | 10.00 | 9.00 | - | - | - | - | - | - | - |
| Liabilities | -3.8% | 36.00 | 38.00 | 52.00 | 53.00 | 46.00 | 44.00 | 46.00 | 44.00 | 40.00 | 38.00 | 40.00 |
| Current Liabilities | 8.2% | 20.00 | 19.00 | 19.00 | 19.00 | 15.00 | 14.00 | 15.00 | 13.00 | 11.00 | 9.00 | 11.00 |
| LT Debt, Non Current | - | - | - | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 14.00 |
| Shareholder's Equity | -3.4% | 174 | 181 | 191 | 197 | 201 | 207 | 215 | 123 | 127 | 133 | 139 |
| Retained Earnings | -6.4% | -156 | -146 | -134 | -124 | -118 | -110 | -100 | -97.17 | -92.00 | -84.56 | -78.47 |
| Additional Paid-In Capital | 1.0% | 329 | 326 | 324 | 321 | 319 | 317 | 315 | 220 | 219 | 218 | 217 |
| Shares Outstanding | 0.8% | 32.00 | 32.00 | 32.00 | 32.00 | 31.00 | 31.00 | 31.00 | 28.00 | 27.00 | 27.00 | 27.00 |
Cashflow (Last 12 Months)(In Thousands)
| Cashflow (Last 12 Months) | (In Thousands) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 |
| Cashflow From Operations | 8.1% | -28,583 | -31,111 | -20,930 | -25,034 | -23,020 | -19,915 | -29,082 | -17,530 | -6,409 | -2,334 | 4,131 | 2,399 | -12,796 | -12,672 |
| Share Based Compensation | 8.5% | 8,768 | 8,084 | 7,207 | 6,076 | 4,867 | 3,454 | 2,504 | 1,938 | 1,210 | 798 | 525 | 291 | 270 | 264 |
| Cashflow From Investing | -121.3% | -36,239 | -16,375 | -15,807 | -15,249 | -801 | -1,345 | -737 | -683 | -450 | 73.00 | -9.00 | -12.00 | -368 | -364 |
| Cashflow From Financing | -6.1% | -15,200 | -14,332 | 1,179 | 95,300 | 95,612 | 95,421 | 94,725 | 137,376 | 136,898 | 136,623 | 137,192 | 12.00 | 8.00 | 12.00 |
MASS Income Statement
2023-06-30CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Revenue | $ 12,094 | $ 11,106 | $ 21,581 | $ 19,412 |
| Cost of revenue | 6,300 | 4,472 | 11,403 | 8,649 |
| Gross profit | 5,794 | 6,634 | 10,178 | 10,763 |
| Operating expenses: | ||||
| Research and development | 5,525 | 4,293 | 10,923 | 8,198 |
| Selling, general and administrative | 11,208 | 10,710 | 23,211 | 20,455 |
| Total operating expenses | 16,733 | 15,003 | 34,134 | 28,653 |
| Loss from operations | (10,939) | (8,369) | (23,956) | (17,890) |
| Other income: | ||||
| Interest income | 1,689 | 293 | 2,706 | 464 |
| Interest expense | (15) | (551) | (35) | |
| Other expense, net | (167) | (8) | (200) | (53) |
| Total other income, net | 1,522 | 270 | 1,955 | 376 |
| Loss from operation before income taxes | (9,417) | (8,099) | (22,001) | (17,514) |
| Benefit for income taxes | 71 | 122 | ||
| Net loss | $ (9,346) | $ (8,099) | $ (21,879) | $ (17,514) |
| Net loss per share, basic | $ (0.29) | $ (0.26) | $ (0.68) | $ (0.56) |
| Net loss per share, diluted | $ (0.29) | $ (0.26) | $ (0.68) | $ (0.56) |
| Weighted average common shares outstanding, basic | 32,199,156 | 31,413,431 | 32,083,122 | 31,312,559 |
| Weighted average common shares outstanding, diluted | 32,199,156 | 31,413,431 | 32,083,122 | 31,312,559 |
| Product revenue | ||||
| Revenue | $ 9,595 | $ 9,082 | $ 16,617 | $ 15,589 |
| Cost of revenue | 4,800 | 3,304 | 8,586 | 6,276 |
| Service revenue | ||||
| Revenue | 2,354 | 1,526 | 4,594 | 3,048 |
| Cost of revenue | 1,448 | 1,057 | 2,718 | 2,126 |
| Contract revenue | ||||
| Revenue | 145 | 498 | 370 | 775 |
| Cost of revenue | $ 52 | $ 111 | $ 99 | $ 247 |
MASS Balance Sheet
2023-06-30CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 132,996 | $ 188,422 |
| Marketable securities | 19,691 | 0 |
| Accounts receivable, net of allowance for credit losses of $133 and $25 at June 30, 2023 and December 31, 2022 | 10,308 | 10,033 |
| Inventory | 14,135 | 12,513 |
| Prepaid expenses and other current assets | 3,947 | 4,658 |
| Total current assets | 181,077 | 215,626 |
| Operating lease, right-of-use assets | 7,136 | 3,956 |
| Property and equipment, net | 2,940 | 3,083 |
| Goodwill | 10,185 | 10,050 |
| Intangible assets, net | 8,162 | 8,488 |
| Other long-term assets | 1,330 | 1,384 |
| Total assets | 210,830 | 242,587 |
| Current liabilities: | ||
| Accounts payable | 1,486 | 1,397 |
| Accrued expenses | 6,034 | 8,847 |
| Deferred revenue | 10,814 | 7,514 |
| Operating lease liabilities | 1,860 | 1,468 |
| Total current liabilities | 20,194 | 19,226 |
| Long-term debt | 15,000 | |
| Operating lease liabilities, net of current portion | 4,962 | 3,040 |
| Deferred revenue, net of current portion | 8,474 | 11,496 |
| Deferred income taxes | 2,585 | 2,671 |
| Other long-term liabilities | 156 | 555 |
| Total liabilities | 36,371 | 51,988 |
| Commitments and contingencies | ||
| Stockholders' equity: | ||
| Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued or outstanding at June 30, 2023 and December 31, 2022, respectively | ||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 32,326,861 shares and 31,859,847 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively | 32 | 32 |
| Additional paid-in capital | 329,361 | 323,969 |
| Accumulated other comprehensive income | 1,144 | 798 |
| Accumulated deficit | (156,078) | (134,200) |
| Total stockholders' equity | 174,459 | 190,599 |
| Total liabilities and stockholders' equity | $ 210,830 | $ 242,587 |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.